Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hyperliquid Strategies Inc (PURR)

Hyperliquid Strategies Inc (PURR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hyperliquid Strategies Inc 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 USA

www.sonnetbio.com Employees: 9 P: 609-375-2227

Sector:

Finance

INDUSTRY GROUPING:

Finance - Misc Services

Description:

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 452,213
Enterprise Value, $K 438,853
Shares Outstanding, K 127,026
Annual Sales, $ 1,000 K
Annual Net Income, $ -16,010 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,580 K
EBIT, $ -15,850 K
EBITDA, $ -15,200 K
60-Month Beta 1.48
% of Insider Shareholders 8.48%
% of Institutional Shareholders 9.45%
Float, K 116,254
% Float 91.52%
Short Interest 1,262
Short Float 0.99%
Short Volume Ratio 0.21

Growth:

1-Year Return -11.67%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.95 on 08/13/25
Next Earnings Date 01/06/26 [--]
Earnings Per Share ttm -3.40
EPS Growth vs. Prev Qtr -6.74%
EPS Growth vs. Prev Year 83.04%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PURR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 8.43
Price/Earnings to Growth N/A
Return-on-Equity % -514.78%
Return-on-Assets % -229.07%
Profit Margin % -1,601.00%
Debt/Equity 0.00
Price/Sales 428.08
Price/Cash Flow N/A
Price/Book 2.21
Book Value/Share 1.52
Interest Coverage -0.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar